BIO-key Q3'26 net loss narrows 8% year over year to $886,083
BKYI•BIO-key’s Q3'26 net loss narrowed 8% year over year to $886,083, excluding a $4.5 million noncash deemed dividend, while total revenue fell to $1.48 million. License fee revenue rose 39% to $1.28 million and gross margin increased to 90%.
1. Quarterly results
BIO-key reported a net loss of $886,083 for Q3'26, down 8% year over year excluding a $4.5 million noncash deemed dividend related to an August warrant inducement. Loss per share more than doubled year over year to $4.01, including the deemed dividend.
2. Revenue and customers
Total revenue fell year over year to $1.48 million, while license fee revenue climbed 39% to $1.28 million. Gross margin rose to 90% from 77% a year earlier, reflecting a higher proportion of high-margin license fees. Three government customers added in October brought the number of new Middle East customers to eight over seven months.
